• Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients

  • Feb 12 2024
  • Length: 32 mins
  • Podcast

Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients

Listen for free

View show details

  • Summary

  • In this episode, Jennifer Green, MD, and Carol Hatch Wysham, MD, break down the latest headlines on incretin-based therapies and how to address these topics with patients. Their discussion includes:

    • Beneficial effects beyond glycemic control 
    • Adverse events and how to manage them
    • Non- or partial responders and the importance of setting expectations with patients 
    • Weight rebound when discontinuing therapy
    • Medication access issues related to cost and drug availability 

    Presenters:

    Jennifer Green, MD
    Professor of Medicine
    Division of Endocrinology and Duke Clinical Research Institute
    Duke University School of Medicine
    Durham, North Carolina

    Carol Hatch Wysham, MD
    Clinical Professor of Medicine
    Clinical Endocrinologist
    MultiCare/Rockwood Clinic
    Spokane, Washington

    Link to online program: 
    https://bit.ly/48b6XnW
    Show more Show less
Show more Show less

What listeners say about Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available